PSORIASIS (PSO)
Clinical trials for PSORIASIS (PSO) explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS (PSO) trials appear
Sign up with your email to follow new studies for PSORIASIS (PSO), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New psoriasis drug shows promise in Long-Term trial
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug ESK-001 for people with moderate to severe plaque psoriasis. Participants are adults who have already completed a prior ESK-001 study. They will take ESK-001 twice daily for 24 weeks, and some may later switch…
Matched conditions: PSORIASIS (PSO)
Phase: PHASE3 • Sponsor: Alumis Inc • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Fasting diet shows promise for psoriasis relief
Symptom relief OngoingThis pilot study explores whether a 7-day fast followed by 11 weeks of a plant-based diet can reduce skin and joint symptoms in people with psoriasis and psoriatic arthritis. Researchers will also look at changes in gut bacteria and overall quality of life. The study involves 30 …
Matched conditions: PSORIASIS (PSO)
Phase: NA • Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
Doctor education may boost use of cheaper biologic drugs
Knowledge-focused OngoingThis study looks at whether offering doctors educational meetings about biosimilar medications leads them to prescribe more of these lower-cost alternatives instead of the original brand-name drugs. About 1,325 clinicians who prescribe adalimumab for conditions like rheumatoid ar…
Matched conditions: PSORIASIS (PSO)
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Fatty liver and psoriasis study pulled before it started
Knowledge-focused TerminatedThis study aimed to understand the link between non-alcoholic fatty liver disease (NAFLD) and psoriatic disease (psoriasis and psoriatic arthritis) in overweight adults. Researchers planned to use the drug guselkumab (Tremfya) to see if it improved both conditions. However, the t…
Matched conditions: PSORIASIS (PSO)
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC